Author

Abeer Shibli

Institution: Children's National

Observed institution: Children's National

OpenAlex ID: A5081175813

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

2022 · Hannah Kinoshita, Kenneth R. Cooke, et al. · Blood Advances · 38

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

2024 · Michael D. Keller, Patrick J. Hanley, et al. · Nature Communications · 30

Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

2021 · Hema Dave, Madeline Terpilowski, et al. · Blood Advances · 19

The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy

2024 · Cynthia L Gay, Patrick J Hanley, et al. · The Journal of Infectious Diseases · 14

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease

2022 · Hannah Kinoshita, Mamatha Mandava, et al. · Blood Advances · 11

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study

2025 · Danielle K. Sohai, Michael D. Keller, et al. · Nature Communications · 5

IMMU-23. RESEARCH ON MULTI-ANTIGEN T CELL INFUSION AGAINST NEURO-ONCOLOGIC DISEASE (ReMIND)

2023 · Conrad Russell Cruz, Stephanie Gomez, et al. · Neuro-Oncology · 2

Tumor Associated Antigen Specific T Cells Given in Combination with Nivolumab for the Treatment of Hodgkin Lymphoma

2020 · Hema Dave, Mimi Mai, et al. · Blood · 2

Outcome Analysis Post Virus-Specific T Cell Therapy for the Treatment of Adenoviremia in Immunocompromised Pediatric Patients

2025 · Navid Djassemi, Hannah Kinoshita, et al. · Transplantation and Cellular Therapy · 1

IMMU-19. Outcomes of Pediatric Patients with High-Risk CNS Tumors Treated with Multi-tumor associated antigen specific T cell (TAA-T) therapy: the ReMIND trial

2022 · Eugene Hwang, Fernanda Fortiz, et al. · Neuro-Oncology · 1

Outcome of Donor-Derived Tumor Associated Antigen-Specific T Cell Therapy in Patients with High-Risk or Relapsed Acute Leukemia Post Allogeneic BMT

2021 · Hannah Kinoshita, Kenneth R. Cooke, et al. · Blood

Works count: 11

Citation count: 123

H-index: 5

I10-index: 5